Spots Global Cancer Trial Database for metastatic pancreas cancer
Every month we try and update this database with for metastatic pancreas cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer | NCT01586611 | Metastatic Panc... | 5FU, leucovorin... Gemcitabine | 18 Years - | AHS Cancer Control Alberta | |
| Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas | NCT00038701 | Pancreatic Neop... | TNP-470 | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas | NCT00038701 | Pancreatic Neop... | TNP-470 | 18 Years - | M.D. Anderson Cancer Center | |
| A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | NCT02021422 | Pancreas Cancer | anakinra Oxaliplatin Irinotecan fluorouracil | 18 Years - | Baylor Research Institute | |
| Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer | NCT03086642 | Pancreatic Canc... | Talimogene lahe... | 18 Years - | Columbia University | |
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX | NCT03126435 | Metastatic Panc... Locally Advance... Pancreatic Aden... | EndoTAG-1 Gemcitabine | 18 Years - | SynCore Biotechnology Co., Ltd. | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) | NCT02885727 | Metastatic Panc... | Durvalumab Radiation Thera... | 18 Years - | University of Maryland, Baltimore | |
| Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer | NCT03086642 | Pancreatic Canc... | Talimogene lahe... | 18 Years - | Columbia University | |
| Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer | NCT04897854 | Metastatic Panc... | Folfirinox | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX | NCT03126435 | Metastatic Panc... Locally Advance... Pancreatic Aden... | EndoTAG-1 Gemcitabine | 18 Years - | SynCore Biotechnology Co., Ltd. | |
| A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | NCT02021422 | Pancreas Cancer | anakinra Oxaliplatin Irinotecan fluorouracil | 18 Years - | Baylor Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
